By Kelly Stewart
More than half of US adults rely on pharma medications to manage conditions and extend their lives. As such, recipe authoring is one of the most critical phases of drug development.
Done on paper, recipe authoring can lead to transcription errors, process delays, and costly deviations. When done using a legacy or traditional MES, it takes months or years to configure, requires numerous experts and coders, and results in a mountainous heap to manage for years. But when done efficiently, leveraging modern techniques and tools, time-to-market is reduced — meaning people receive the medications they need sooner.
In this white paper, we’ll explore some of the most commonly encountered challenges associated with recipe development and how going digital enables companies to turn molecules into medicine in a fraction of the time.